OPSYNVI Trademark

Trademark Overview

On Friday, February 10, 2017, a trademark application was filed for OPSYNVI with the United States Patent and Trademark Office. The USPTO has given the OPSYNVI trademark a serial number of 87331161. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 12, 2020. This trademark is owned by Actelion Pharmaceuticals Ltd. The OPSYNVI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular and pulmonary diseases; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of auto-immune disorders; pharmaceutical preparations for the treatment of digital ulcers; pharmaceutical preparations for the treatment of glycolipid storage diseases; pharmaceutical preparations for the treatment of cerebrovascular diseases; pharmaceutical preparations for the treatment of gastrointestinal disorders; pharmaceutical anti-allergic preparations and substances; anti-infectives
opsynvi

General Information

Serial Number87331161
Word MarkOPSYNVI
Filing DateFriday, February 10, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 12, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 11, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular and pulmonary diseases; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of auto-immune disorders; pharmaceutical preparations for the treatment of digital ulcers; pharmaceutical preparations for the treatment of glycolipid storage diseases; pharmaceutical preparations for the treatment of cerebrovascular diseases; pharmaceutical preparations for the treatment of gastrointestinal disorders; pharmaceutical anti-allergic preparations and substances; anti-infectives

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 15, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameActelion Pharmaceuticals Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAllschwil CH-4123
CH
Party NameActelion Pharmaceuticals Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAllschwil CH-4123
CH

Trademark Events

Event DateEvent Description
Tuesday, October 13, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 12, 2020ABANDONMENT - NO USE STATEMENT FILED
Saturday, March 14, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 13, 2020EXTENSION 5 GRANTED
Thursday, March 5, 2020EXTENSION 5 FILED
Friday, March 13, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 5, 2020TEAS EXTENSION RECEIVED
Saturday, August 31, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 29, 2019EXTENSION 4 GRANTED
Thursday, August 29, 2019EXTENSION 4 FILED
Thursday, August 29, 2019TEAS EXTENSION RECEIVED
Friday, March 1, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 27, 2019EXTENSION 3 GRANTED
Wednesday, February 27, 2019EXTENSION 3 FILED
Wednesday, February 27, 2019TEAS EXTENSION RECEIVED
Saturday, September 1, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 30, 2018EXTENSION 2 GRANTED
Thursday, August 30, 2018EXTENSION 2 FILED
Thursday, August 30, 2018TEAS EXTENSION RECEIVED
Tuesday, March 6, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 6, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 7, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 5, 2017EXTENSION 1 GRANTED
Tuesday, December 5, 2017EXTENSION 1 FILED
Tuesday, December 5, 2017TEAS EXTENSION RECEIVED
Tuesday, September 5, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 11, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 11, 2017PUBLISHED FOR OPPOSITION
Wednesday, June 21, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 12, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 12, 2017EXAMINER'S AMENDMENT ENTERED
Friday, May 12, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, May 12, 2017EXAMINERS AMENDMENT E-MAILED
Friday, May 12, 2017EXAMINERS AMENDMENT -WRITTEN
Monday, May 8, 2017ASSIGNED TO EXAMINER
Wednesday, February 15, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, February 14, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

opsynvi preparations pharmaceutical treatment diseases anti disorders gastrointestinal cerebrovascular cardiovascular allergic